Introduction
Local thrombolysis is an alternative to the surgical treatment of peripheral arterial occlusions. It is only effective, however, when the occlusion is due to a lesion which is still capable of being lysed i.e. it must contain non-organised fibrin. In addition, thrombolysis is a justifiable alternative only when the prospects of success are comparable to those of surgery and when the risks are not greater. As with vascular surger~ specialists in thrombolytic therapy have used different techniques with various thrombolytic agents in varying doses and have obtained varying results.
We now have 14 years experience with over 1000 cases of peripheral arterial occlusions treated by local *The follow-up investigations of the patients and statistical evaluation of the data were performed by Petra Neller as part of her dissertation for a doctorate from the Medical Faculty of the LudwigMaximilian University, Munich thrombolysis. During the first 6 years we used streptokinase (SK) and urokinase (UK). ~ Since November 1986 a genetically engineered recombinant tissuetype plasminogen activator (rt-PA) has been available to us. Physiologically this activator is synthesised in vessel endothelium and when released locally it lyses intravascular thrombi spontaneously, requiring only minimal quantities. With thrombi in vessels with arteriosclerotic changes, however, adequate spontaneous lysis very seldom occurs, the reason for this is that probably because the diseased artery cannot synthesise and release sufficient amounts of plasminogen activator. The controlled introduction of rt-PA into an obstructing thrombus substitutes this deficiency and succeeds in dissolving the thrombus in an almost physiological way. For this, as with spontaneous lysis, only minimal amounts of rt-PA are required. Unlike SK or UK, rt-PA has little affinity for free circulating plasminogen but high affinity for fibrin-bound plasminogen and has a short half-life of only 3-6 min. 2 We report here our results and experience with local thrombolytic treatment of peripheral arterial occlusions with rt-PA.
Material and Methods

Patients
Within a period of 4 years we treated 288 patients suffering from peripheral arterial occlusion with local low-dose thrombolytic therapy with rt-PA. Of these 16 patients had occlusions in both legs and these were treated during two sessions with an interval of at least 2 days between them. There were, therefore, altogether 304 peripheral occlusions.
Of the 288 patients 139 were male and 149 female with ages ranging between 24 and 88 years (average 71 years). Two hundred and thirty-five of the 304 arterial occlusions were due to thromboses, 41 to primary emboli, 10 to emboli secondary to balloon angioplasty and 18 were graft occlusions.
Localisation of the occlusions was as follows: Superficial femoral artery down to the popliteal artery excluding the trifurcation 202 (of which 18 were grafts); femoropopliteal segment including the trifurcation 92; iliac artery 4; isolated occlusions of the arteries in the calf 6.
Dosage
In association with a multicentre study the first 10 patients received 10 mg rt-PA per hour for a maximum of 5 h. The total dose fluctuated between 10 and 50 mg rt-PA (average 15.75 mg) and the duration of treatment between 60 and 300 min (average 107 min). 3 Eleven treatments were performed using 5 mg rt-PA per hour. The total dose here fluctuated between 0.88 and 12.75 mg (average 7.8 mg) and the duration of treatment between 15 and 160 min (average 92 min). In the remaining 283 treatments 2.5 mg rt-PA per hour was administered. The total dose varied between 0.4 mg and 12.5 mg (average 2.97 mg) and the duration of treatment between 10 and 385 min (average 78 min).
Technique
In comparison to our study with streptokinase and urokinase 1 the technical procedure was changed only in that instead of giving the thrombolytic agent intermittently at intervals of 3 min, rt-PA was administered as a continuous infusion of 0.5 ml solution per min. In order to infiltrate the thrombus it is important that a simple catheter (5, 6 or 7 French) with only one terminal opening is used and as a rule this is introduced in the direction of the occlusion via an ipsilateral puncture of the common femoral artery. With occlusions of the pelvic artery or the common femoral artery and its bifurcation, a cross-over technique may be necessary for introducing the catheter.
In contrast to other techniques in which a catheter is introduced into the occlusion and through which the thrombolytic agent is infused for many hours with the catheter remaining in the same position, in our procedure the attending physician remains with the patient throughout the entire intervention which is always performed under local anaesthesia and without any premedication. With a continuous infusion the catheter is advanced stepwise so that each stenosis is recognised. In this way lysis of even extensive thrombi can be achieved in the shortest possible time with a minimum amount of thrombolytic agent. In addition, residual high-grade stenoses can be identified and dilated during the same session.
Prophylaxis
In order to prevent early reocclusion each patient received I g of acetylsalicylic acid commencing on the day before the intervention and thereafter for at least 10 days. In contrast to treatment with SK, low-dose rt-PA gives rise to only small amounts of heparin -like fibrinogen split products. It is, therefore, necessary to give 5000 IU of heparin during the intervention. With local lysis of lengthy thrombotic occlusions or with poor outflow it is advisable to give heparin i.v. or s.c. monitored by PTT values for a further 2-3 days and then a platelet aggregation inhibitor alone for longterm therapy. With local lysis of primary embolic occlusions, long-term anticoagulation therapy alone is used for the prevention of recurrent emboli. Heparin is given concomitantly with phenprocoumon until the Quick-Test value has reached 30% and thereafter longterm anticoagulation therapy is continued with phenprocoumon alone. We proceed in the same way following successful lysis of a graft occlusion as we believe that anticoagulation is more effective than platelet aggregation inhibition in preventing new occlusions.
Eur J Vasc Endovasc Surg Vol 12, July 1996 
Long-term study and statistical methods
All patients underwent a clinical examination 2 weeks after local lysis. This included palpation of the peripheral pulses, auscultation of the vessels, ultrasound Doppler pressure values and Duplex sonography. If there was any doubt angiography was also performed. Patients who did not have successful recanalisation at that time were considered to be failures. All patients in whom successful recanalisation had persisted for 14 days were contacted by telephone or in writing using a standard questionnaire. Every patient who indicated even only the slightest deterioration in his/her symptoms since the primary successful treatment using the above mentioned methods was requested to,attend for a follow-up examination. The purpose of the investigation was to show whether an occlusion or a haemodynamically effective stenosis (greater than 70%) had occurred in the treated vessel segment. In patients who admitted to a deterioration in their condition but who failed to attend for followup examination it was assumed that an occlusion had occurred. Three patients could not be traced and 27 patients died during the period of observation. The cumulative patency was determined by means of the life-table method. 4
Results
Early results
Early results of 304 peripheral arterial occlusions in 288 consecutive patients treated with local rt-PA are summarised in Table 1 . Two hundred and seventy-two of these occlusions could be reopened primarily and 65 of these had early reocclusions within the first 2 weeks. A second lysis was attempted in 33 of these early reocclusions, 19 of which remained successful for 2 weeks. Thus 74.3% of all occlusions were treated successfully.
Early success in 41 embolic occlusions was higher (82.9%) compared to 235 thrombotic occlusions (71.5%). Macroemboli resulting from primary angioplasty were rapidly dissolved in nine out of 10 cases. Seventeen out of 18 occlusions in femoropopliteal or femorocrural prostethic grafts were opened primarily; seven of these had early reocclusions of which five remained open for 2 weeks following a successful second lysis. Thus, from 19 occluded grafts 15 (83.3%) were treated successfully. In 10 patients the cause of the occlusion was stenosis of the distal anastomosis which in seven cases could be successfully removed by dilatation. In one case the runoff route was corrected surgically subsequent to successful primary lysis and at the same time an AV shunt was performed. Of the 304 occlusions treated with local lysis, 175 (57.6%) were also dilated. Of these six (14.6%) were from 41 embolic occlusions, 156 (66.4%) from 235 thrombotic occlusions, 10 (55.6%) from 18 graft occlusions and three (30.0%) from 10 occlusions caused by macroemboli following angioplasty.
The chances of success of local lysis with rt-PA depending on the type and duration of an occlusion is shown in Table 2 . Particularly rapid thrombolysis of longer arterial occlusions was achieved regularly when these were just a few days old. Occlusions of prosthetic grafts less than 4 weeks old were successfully lysed in 100% of cases. If the occlusion was between 4 and 16-weeks-old, successful lysis was achieved in only 40%. The results with over 6 months old thrombotic occlusions treated with rt-PA were also The severity of the circulatory disturbances according to the Fontaine classification did not influence the early results. The 2 weeks patency rate after treatment were practically the same with 63.8 to 69.7% in all stages (Fig. 1) . The early success, however, did depend upon the length of the occlusion; with 2 weeks continuous recanalisation of occlusions less than 5 cm it was 80.8%, with 5-10 cm 69.2%, and from 10 to over 25 cm 55% (Fig. 2) .
We observed that older patients had better early results of local lysis with rt-PA. Recanalisation was primarily successful in about 90% of patients regardless of age. In contrast, success was maintained for 2 weeks only in 50% of patients under the age of 50 whereas in those between 51 and 60 it was 57%, between 61 and 70, 69%, between 71 and 80, 66% and over 80 it was 78% (Fig. 3) . 
Long-term results
Of 304 arterial occlusions in 288 patients 226 could be opened by local lysis with rt-PA and the success was maintained continuously for 2 weeks. In three patients the further course could not be ascertained. The cumulative patency calculated from 223 peripheral occlusions treated successfully with rt-PA was 81.9% after 2 years and also after 4 years. The results after 4 years, however, are not reliable because of the small number of patients followed up for so long. Macroemboli following primary catheter dilatation have the best long-term prognosis with 100%, followed by primary embolic occlusions with 94.7% patency after 4 years. This is followed by thrombotic occlusions with 79.7% and then graft occlusions with 67.2% (Fig. 4) . In some of our patients, however, haemodynamically significant stenoses have recurred over the years. The overall 2 years patency without any high-grade haemodynamically effective Stenosis was 61.7%.
Cumulative long-term patency was found to be independent of the age and sex of the patient. Successfully treated occlusions of the popliteal artery including the trifurcation have an unexpected good long-term prognosis (89.0%) which is not significantly different when compared to segmental occlusions of the femoral or popliteal arteries with open trifucation (78.8%) (p = 0.128). Segmental occlusions up to 25 cm length have practically as good a chance after 2 years with patency between 79 and 89.4%; with even longer occlusions the value is only 65.3%.
Long-term prognosis also depends on the clinical presentation at the time of treatment. In Fontaine Stage IIA patients, cumulative patency after 2 years is 100%, in Stages IIA and III patients it is 83% and in Stage IV patients 51% (p < 0.01).
Failures and complications
The main reason for failure of treatment was penetration of the catheter into the vessel wall which occurred in 9% of the 336 treatments with lysis. In 7% of the treatments either the thrombus was organised and the catheter could no longer pass through or the guide wire constantly diverged off into a collateral vessel. All complications which occurred during the interventions and during inpatient treatment are summarised in Table 3 . In 26 (7.7%) treatments a peripheral macroembolus into run-off vessels occurred of which 22 were dissolved either during the intervention under continued local lysis or some hours later by the after-lysis effect. The remaining four macroembolisms did not give rise to any deterioration. The only systemic haemorrhage with rt-PA was gastric bleeding in a patient who had received 10 mg rt-PA per hour for 5 h i.e. a total of 50 fng together with 5000 IU heparin. Of seven haematomas at puncture sites, six (1.7%) were of moderate size, one (0.3%) required volume substitution but none needed surgical evacuation.
Major amputations (below knee, above knee) were necessary in two patients after unsuccessful lysis and in four further cases following late reocclusions. Two patients had forefoot and toe amputations respectively. Bypass operations were necessary in four cases following unsuccessful lysis, in two after early occlusions within 2 weeks after lysis and in three after late reocclusions. A further four patients had aneurysms of the popliteal artery removed by graft operations. In one case it was necessary to perform embolectomy to restore the vascular circulation after both lysis and aspiration had proved to be unsuccessful.
Discussion
Early and long-term results with local low-dose rt-PA thrombolytic therapy are better than those which we obtained in previous years with SK and UK. 1 From this it can be concluded without any doubt that local thrombolytic treatment has become more successful from study to study. This is certainly due in part to our increasing experience with diagnosis and technique. The superiority of rt-PA over SK and UK cannot be unequivocally deduced from these results and can only be determined in a randomised study. Even more caution is required when our results are compared with those of other authors who used other methods and different doses of SK, UK or rt-PA over varying periods of time for local thrombolytic treatment. 5-~4 Further, in such a comparison the patient populations under investigation must be comparable particularly with regard to how long the occlusion has existed and also the type (thrombotic, embolic). Our early results with 89.5% primary recanalisations of all types of occlusions are, nevertheless, comparable to the best results of all published studies to date. As far as studies with rt-PA are concerned, these results were achieved with the smallest doses mentioned until now, namely 0.4 mg to 15.5 mg (average total 2.97 mg rt-PA) and a treatment time of 10 to 385 min (average 78 min). In a comparable study in which 10 mg rt-PA were infused blindly for a period of 6 h each time via a catheter placed at the proximal end of the occlusion, patency was achieved in 31% of the cases after 6 h treatment (10 mg rt-PA), in 60.5% after 12 h (20 mg rt-PA) and in 67.1% after 24 h (40 mg rt-PA), s Another study treated 15 femoropopliteal bypass occlusions and a segmental femoral arterial occlusion with 10 mg rt-PA as a bolus followed by 5 mg/hour as a blind local infusion up to a maximum of 24 h and achieved patency in 25% of the cases after 4 h (30 mg rt-PA), in 44% after 8-16 h (50-90 mg rt-PA) and in only 50% after 24 h (130 mg rt-PA). The average age of the occlusions here was only 9.3 days. 6 The main reasons for early reocclusions following successful recanalisation were slowing of the blood flow due to poor run-off in the periphery and highgrade residual stenoses which we had underestimated. Most bypass occlusions were due to disparity between the diameter of the graft and the artery of the distal anastomosis or a reocclusion of the latter due to high-grade stenosis. Dilatation of high-grade stenoses should generally be performed during the same session and should be strictly limited to the stenosed segment.
In many centres occlusions in femoropopliteal or femorocrural grafts are managed surgically. In 15 out of 18 such occlusions continuous patency was achieved by local lysis although five required a second lysis. We recommend that whenever possible local lysis should always be attempted first with graft occlusions.
The strategy of treating acute peripheral ischaemia should be reconsidered. Until now acute critical ischaemias, i.e. threatened viability or irreversible ischaemic changes has been managed surgically to provide rapid revascularisation. This is true as far as acute embolic occlusions of the arteries of the arms, the abdominal aorta, the pelvic arteries, the common femoral arteries and their bifurcations are concerned. With embolic occlusions of the superficial femoral arteries, popliteal arteries and arteries of the lower leg, embolectomy in the first days following the acute incident has a high probability of success, however, becoming less so from day to day. Follow-up investigations in patients who had had embolectomy of the femoropopliteal segment have shown that only one third was permanently successful, one third was unsuccessful from the beginning and the remaining third showed angiographic evidence of arteriosclerotic changes in the section of the vessel through which the balloon catheter had been drawn. 17 It is necessary to consider further that in many cases it can be difficult to distinguish embolus from thrombus. In thrombotic occlusions a Fogarty embolectomy has little prospect of success and local lysis following it has also unfortunately no greater success. Where critical ischaemia is present in the case of a thrombotic occlusion a femorocrural bypass with all its problems is usually performed. When local lysis is the intervention of choice it is immaterial whether the acute occlusion is embolic or thrombotic. In our experience, in both embolic and thrombotic acute occlusions of the femoropopliteal and femorocrural arteries with critical ischaemia, local lysis can restore the blood flow practically as quickly and with at least the same prospect of success as surgical procedures. Should the intervention fail, immediate surgical procedures are possible. When this occurs, in most cases conditions are not any worse than they were before the unsuccessful local lysis. It must be admitted, however, that further deterioration in the blood flow can occur as a complication of the lytic procedure which could make the previous possibility of surgery more difficult or even impossible. Therefore, modern treatment of acute critical ischaemia requires close cooperation between angiologists, radiologists performing the intervention and vascular surgeons.
In our 336 treatments with rt-PA we had no hospital deaths, no new systemic embolization and only one systemic (gastrointestinal) bleeding following 10 mg rt-PA per hour for 5 h (total dose 50 mg) and 5000 IU heparin. In 1.7% of the treatments severe bleeding occurred from the puncture site and of these one patient (0.3%) required volume replacement therapy but none required surgical care. In the studies already mentioned in which higher doses of rt-PA and longer periods of treatment were required, bleeding complications were considerably more frequent particularly where 30-130 mg of rt-PA were administered over 4-24 h. 5"6 In a literature review on local thrombolytic treatments with different techniques, drugs and dosages, the following averages are cited: 2% extensive bleeding from the puncture site requiring surgical treatment, about 1% severe systemic bleeding (cerebral, gastrointestinal renal) and 1.1% hospital deaths correlated to treatment. ~s Some of the bleeding complications were certainly due to the administration of heparin which in most cases was given concomitantly. Heparin was also used in our study so that it can be assumed that the low total doses of rt-PA was followed by less local bleeding complications.
We feel there are very few contraindications to local lysis using very low-dose rt-PA. Even if there is no risk of a substantial activation of systemic fibrinolysis with very low doses rt-PA, florid gastrointestinal and cerebral haemorrhages still remain contraindications.
A further contraindication is a sufficiently well compensated occlusion of the popliteal artery based on an aneurysm of this vessel. When this, however, is accompanied by critical ischaemia and the angiogram shows concomitant occlusion of all three large arteries of the lower limb, then the prospect exists, as in three of our cases, that local lysis will reopen peripheral arteries allowing surgical removal of the aneurysm.
From the results of our study we conclude that local thrombolytic treatment of peripheral arterial occlusions with 2.5 mg rt-PA per hour for a maximum of 3-5 h using the technique recommended by us has good prospects of success with hardly any risk of systemic bleeding or embolisation. Monitoring of coagulation parameters is, therefore, not necessary. Our continuous controlled method has several advantages compared to the methods where a catheter is placed directly at the origin of an occlusion or even inserted into it and then rt-PA is infused for several hours in an uncontrolled way. They are as follows: (1) The total dose of rt-PA required is low (in our case an average of 2.97 mg). Because of this there is hardly any risk of bleeding or systemic embolism occurring and the cost of the thrombolytic agent is relatively low. (2) . Due to the relatively short time the catheter remains in the artery the risk of percatheter thrombosis developing is low. (3) There is a comparable rapid restoration of flow and therefore it is also suitable for treating acute critical ischaemia. (4) Avoidance of repeated transporting and transferring patients with an indwelling intra-arterial catheter.
